Dr. Rebecca Ball provides advice on virtually all aspects of U.S. and foreign patent prosecution, post-grant proceedings, IP licensing and other IP agreements, opinions, due diligence and strategic development and management of patent portfolios for corporate and academic clients. In everything she does, Becky provides an impressive mix of technological skill, scientific acuity and legal proficiency.
Becky has deep legal and technical experience in the pharmaceutical and biotechnology areas, ranging from pharmaceutical products, molecular biology-based technologies, antimicrobial agents and vaccines to antitumor agents and diagnostic assays. Technical depth is the hallmark of Becky’s patent prosecution and counseling practice.
Meticulous, careful, thorough, clear and concise, Becky is focused on providing efficient solutions for her clients that safeguard their assets. Becky consistently delivers high-quality work product and attention to detail for each matter in which she is involved. She is valued by clients and colleagues alike for her ability to understand sophisticated technologies and complex innovations very quickly, and to integrate the patent laws and technology.
Prior to joining the firm, Becky worked in biochemistry, microbiology and molecular biology research for nearly two decades, with postdoctoral training in biochemistry at Vanderbilt University to study tyrosine kinase receptor-mediated signaling. She also served as a research scientist studying G protein-mediated signaling through the inositol phosphate signaling pathway using a molecular cloning approach. Her work is published in Science (Volume 273, pages 956-959), the Journal of Biological Chemistry(Volume 265, pages 12836-12845), and the Journal of Cell Biology (Volume 103, 1033-1041).
Member, Sigma Xi
Member, American Association for Advancement of the Sciences
National Dean’s List, Who’s Who Among Students in American Colleges and Universities
Who’s Who in Science and Engineering